Telitacicept Following Plasma Exchange in the Treatment of Subjects With Recurrent NMOSD: Study Protocol for a Single-Center, Single-Arm, Open-Label Study

Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune demyelinating disease that recurrently relapses and leads to severe disability. The available choices for disease prevention are few or intolerable. Previous studies suggested that telitacicept may provide a promising therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jie, Cai, Yu, Deng, Ye, Jiang, Xianguo, Gao, Meichun, Lin, Yan, Zhao, Nan, Wang, Ze, Yu, Haojun, Lv, Wenwen, Zhang, Ying, Hao, Yong, Guan, Yangtai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044936/
https://www.ncbi.nlm.nih.gov/pubmed/33868140
http://dx.doi.org/10.3389/fneur.2021.596791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044936/
https://www.ncbi.nlm.nih.gov/pubmed/33868140
http://dx.doi.org/10.3389/fneur.2021.596791

Ejemplares similares